These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2233427)

  • 1. Bone marrow transplantation.
    Ekert H
    Med J Aust; 1990 Nov; 153(10):573-4. PubMed ID: 2233427
    [No Abstract]   [Full Text] [Related]  

  • 2. In utero stem cell therapy.
    Diukman R; Golbus MS
    J Reprod Med; 1992 Jun; 37(6):515-20. PubMed ID: 1619604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation.
    Curr Opin Oncol; 1997 Mar; 9(2):B41-7. PubMed ID: 9161802
    [No Abstract]   [Full Text] [Related]  

  • 4. Autologous blood stem cell grafting in hematological malignancies. Present status and future directions.
    Reiffers J; Marit G; Vezon G; Cony-Makhoul P; Boiron JM; Montastruc M; Rice A; Broustet A
    Transfus Sci; 1992; 13(4):399-405. PubMed ID: 10147738
    [No Abstract]   [Full Text] [Related]  

  • 5. Bone marrow transplantation using unrelated bone marrow donors--a technology in evolution.
    Buskard NA
    Transfus Sci; 1991; 12(3):111-8. PubMed ID: 10149540
    [No Abstract]   [Full Text] [Related]  

  • 6. Alemtuzumab Pharmacokinetics in Hematopoietic Stem Cell Transplants for Nonmalignant Genetic Diseases.
    Jain A; Sahdev I
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1337. PubMed ID: 25963918
    [No Abstract]   [Full Text] [Related]  

  • 7. Bone marrow transplantation.
    Harbin P
    Nursing (Lond); 1991 Sep 12-25; 4(41):19-22. PubMed ID: 1945107
    [No Abstract]   [Full Text] [Related]  

  • 8. CD34 selection for bone marrow transplants for children with genetic diseases.
    Shaw PJ; Bleakley M
    Bone Marrow Transplant; 2004 Feb; 33(3):351; author reply 353. PubMed ID: 14676786
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of non-myeloablative conditioning in allowing engraftment of allogeneic hematopoietic cells for correction of genetic disorders and for immunotherapy of leukemia.
    Awedan A
    Ann Transplant; 2001; 6(1):9-13. PubMed ID: 11803609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation.
    Jones RJ
    Curr Opin Oncol; 1997 Mar; 9(2):115-6. PubMed ID: 9161786
    [No Abstract]   [Full Text] [Related]  

  • 11. Bone marrow transplantation for immunodeficiency and genetic diseases.
    Lenarsky C; Kohn D; Parkman R
    Cancer Treat Res; 1990; 50():167-84. PubMed ID: 1976349
    [No Abstract]   [Full Text] [Related]  

  • 12. Mayo Clinic experience with allogeneic and syngeneic bone marrow transplantation, 1982 through 1990.
    Letendre L; Hoagland HC; Moore SB; Chen MG; Gastineau DA; Gertz MA; Habermann TM; Litzow MR; Noël P; Solberg LA
    Mayo Clin Proc; 1992 Feb; 67(2):109-16. PubMed ID: 1312187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Third International Symposium on recent advances in hematopoietic stem cell transplantation. Clinical progress, new technologies and gene therapy, March 16-18, 1995, San Diego, CA.
    Ghielmini M
    Ann Oncol; 1995 Jul; 6(6):533-6. PubMed ID: 8573530
    [No Abstract]   [Full Text] [Related]  

  • 14. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors.
    Morishima Y; Sasazuki T; Inoko H; Juji T; Akaza T; Yamamoto K; Ishikawa Y; Kato S; Sao H; Sakamaki H; Kawa K; Hamajima N; Asano S; Kodera Y
    Blood; 2002 Jun; 99(11):4200-6. PubMed ID: 12010826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How do BMTs cure leukaemia? New directions.
    Prentice HG
    Bone Marrow Transplant; 1991; 7 Suppl 2():11-3. PubMed ID: 1878667
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bone marrow transplantation in acute leukemias: the arguments pro and con].
    Savchenko VG; Parovichnikova EN; Liubimova LS; Mendeleeva LP
    Ter Arkh; 1993; 65(7):7-18. PubMed ID: 8211785
    [No Abstract]   [Full Text] [Related]  

  • 17. Morbidity and non-relapse mortality after allogeneic bone marrow transplantation in adult leukemia patients conditioned with busulfan plus cyclophosphamide: a retrospective comparison of oral versus intravenous busulfan.
    Kim SE; Lee JH; Choi SJ; Lee JH; Ryu SG; Lee KH
    Haematologica; 2005 Feb; 90(2):285-6. PubMed ID: 15710597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty-five years of gene therapy for genetic diseases and leukemia: The road to marketing authorization of the first ex vivo gene therapies.
    Bordignon C
    J Autoimmun; 2017 Dec; 85():98-102. PubMed ID: 28724503
    [No Abstract]   [Full Text] [Related]  

  • 19. 50 years of allogeneic bone-marrow transplantation.
    Powles R
    Lancet Oncol; 2010 Apr; 11(4):305-6. PubMed ID: 20359656
    [No Abstract]   [Full Text] [Related]  

  • 20. Adolfo Ferrata Lecture 1991. Bone marrow transplantation: past, present and future.
    Thomas ED
    Haematologica; 1991; 76(5):353-6. PubMed ID: 1806436
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.